a e b-glucosidases como alvos moleculares para desenvolvimento de fármacos



Document title: a e b-glucosidases como alvos moleculares para desenvolvimento de fármacos
Journal: Quimica nova
Database: PERIÓDICA
System number: 000313202
ISSN: 0100-4042
Authors: 1
2
Institutions: 1Universidade Estadual do Oeste do Parana, Colegiado de Farmacia, Cascavel, Parana. Brasil
2Universidade de Sao Paulo, Faculdade de Ciencias Farmaceuticas de Ribeirao Preto, Ribeirao Preto, Sao Paulo. Brasil
Year:
Season: Jul
Volumen: 29
Number: 4
Pages: 840-843
Country: Brasil
Language: Portugués
Document type: Artículo
Approach: Experimental, aplicado
English abstract Glucosidases are involved in key steps in the processing of oligosaccharides by cleaving O-glucose residues. Since they catalyze breaking and transfer reactions of glucosidic groups for the normal growth and development of all the cells, defects or genetic deficiencies in these enzymes are associated with serious disorders of the carbohydrate metabolism. Thus, glucosidases represent important targets to develop inhibitors, owing to their potential activities against viruses, tumoral growth and metastasis, diabetes, Gaucher's disease and other syndromes associated with the lisosomal storage of glucoesphingolipids, and osteoarthritis. This paper presents a description of the biochemical pathways and mechanisms of alpha and beta-glucosidases, and the currently available drugs capable to inhibit these enzymes
Disciplines: Química
Keyword: Química farmacéutica,
Alfa-glucosidasa,
Beta-glucuronidasa,
Desarrollo de fármacos,
Diabetes,
Enfermedad de Gaucher
Keyword: Chemistry,
Medicinal chemistry,
Alpha-glycosidase,
Beta-glycosidase,
Drug development,
Diabetes,
Gaucher disease
Full text: Texto completo (Ver HTML)